Should I Buy ACAD Stock in 2026?
Data-driven analysis and honest assessment for ACADIA Pharmaceuticals Inc
Current Price: $0.00P/E: 15.3
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Reasonable P/E of 15.3
Growth data limited
Profitability data limited
Financial health data limited
Cash flow data limited
No recent insider activity
Key Investment Metrics
Current Price
$0.00
P/E Ratio
15.29
Revenue Growth
N/A
Profit Margin
N/A
Market Cap
$3.5B
Dividend Yield
None
How ACAD Compares to Competitors
Understanding how ACAD stacks up against peers helps inform your investment decision.
How ACAD Compares to Peers
Upcoming Events for ACAD
+5 Reasons TO Buy ACAD
Limited data available to identify compelling buy reasons. Consider this a yellow flag.
-5 Reasons NOT to Buy ACAD
1. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy ACAD?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in ACAD, compare these Healthcare peers:
Pro tip: Compare ACAD directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ACAD
Frequently Asked Questions
What is ACAD stock price today?
Visit our real-time dashboard for the current ACAD stock price and live market data.
Is ACAD stock going up or down today?
ACAD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ACAD stock now?
The decision to buy ACAD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ACAD a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ACAD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ACAD stock overvalued or undervalued?
ACAD currently trades at a P/E ratio of 15.29 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ACAD is fairly priced.
What is ACAD's P/E ratio?
ACAD has a price-to-earnings (P/E) ratio of 15.29, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is ACAD's market cap?
ACAD (ACADIA Pharmaceuticals Inc) has a market capitalization of $3.51 billion, making it a small-cap stock.
What is ACAD's price to book ratio?
Price-to-book ratio for ACAD is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about ACADIA Pharmaceuticals Inc
Full Stock Analysis
Complete ACAD overview with charts and data
Is ACAD Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how ACAD stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to ACADIA Pharmaceuticals Inc
Complete ACAD Analysis
Compare ACAD With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.